Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTD-2561J22.3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | TREML4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | FAM120C | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ARHGEF9 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | PDLIM3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RP11-371E8.4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | MAP3K14 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CTB-54O9.9 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | RP11-467J12.4 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ETV4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |